Live Breaking News & Updates on Chertsey high

Stay informed with the latest breaking news from Chertsey high on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Chertsey high and stay connected to the pulse of your community

Facial Recognition to be Used in UK School's Lunch Payment, Minimizing Touch Amid COVID-19's Threat

Facial recognition to be used in some UK schools’ lunch payment, which could minimize touch amid COVID-19’s threat and speed up the line in the canteen as well.

New-york , United-states , Australia , North-ayrshire , United-kingdom , Chertsey , Surrey , Australian , British , David-swanston , Dan-kitwood-getty , Teejay-boris

Covid-19 news archive: March and April 2021

This is an archive of the
Health
13 April 2021
Nurse Anna Briggs puts down a vial of the Johnson & Johnson COVID-19 vaccine at the Center for Empowering Refugees in collaboration with Native American.
Gabrielle Lurie/The San Francisco Chronicle via Getty Images
Latest coronavirus news as of 5pm on 13 April
There have been six reports of rare blood clots among more than 6.8 million people in the US who received the Johnson & Johnson vaccine
US health authorities, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), recommended a pause in the use of the Johnson & Johnson covid-19 vaccine on 13 April as a precautionary measure, following reports of rare blood clots in six people who had received the vaccine. More than 6.8 million doses of the single-shot vaccine had been administered across the US as of 13 April. Among these, there were six reports of a rare blood clotting condition called cerebral venous sinus thrombosis (CVST), which affects blood vessels in the brain, all of which were among women aged 18 to 48. A special meeting of the CDC’s Advisory Committee on Immunization Practices will review the reports on 14 April, the FDA and CDC said in a joint statement. “Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” the statement said.

United-states , United-kingdom , France , Russia , Germany , Netherlands , Israel , Haridwar , Uttaranchal , India , Australia , Paris

Covid-19 archive: March and April 2021

Covid-19 archive: March and April 2021
The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews from New Scientist and essential information about the covid-19 pandemic
Health
13 April 2021
Nurse Anna Briggs puts down a vial of the Johnson & Johnson COVID-19 vaccine at the Center for Empowering Refugees in collaboration with Native American.
Gabrielle Lurie/The San Francisco Chronicle via Getty Images
Latest coronavirus news as of 5pm on 13 April
There have been six reports of rare blood clots among more than 6.8 million people in the US who received the Johnson & Johnson vaccine
US health authorities, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), recommended a pause in the use of the Johnson & Johnson covid-19 vaccine on 13 April as a precautionary measure, following reports of rare blood clots in six people who had received the vaccine. More than 6.8 million doses of the single-shot vaccine had been administered across the US as of 13 April. Among these, there were six reports of a rare blood clotting condition called cerebral venous sinus thrombosis (CVST), which affects blood vessels in the brain, all of which were among women aged 18 to 48. A special meeting of the CDC’s Advisory Committee on Immunization Practices will review the reports on 14 April, the FDA and CDC said in a joint statement. “Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” the statement said.

United-states , United-kingdom , France , Russia , Germany , Netherlands , Israel , Chile , Italy , City-of-london , London , City-of

Covid-19 news: One vaccine dose produces strong response in over-80s

Covid-19 news: One vaccine dose produces strong response in over-80s
newscientist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newscientist.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , London , City-of , France , Brazil , Bolivia , Russia , Germany , Netherlands , Israel , Haridwar , Uttaranchal

Covid-19 news: US authorities call for Johnson & Johnson vaccine pause

Gabrielle Lurie/The San Francisco Chronicle via Getty Images
Latest coronavirus news as of 5pm on 13 April
There have been six reports of rare blood clots among more than 6.8 million people in the US who received the Johnson & Johnson vaccine
US health authorities, including the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), recommended a pause in the use of the Johnson & Johnson covid-19 vaccine on 13 April as a precautionary measure, following reports of rare blood clots in six people who had received the vaccine. More than 6.8 million doses of the single-shot vaccine had been administered across the US as of 13 April. Among these, there were six reports of a rare blood clotting condition called cerebral venous sinus thrombosis (CVST), which affects blood vessels in the brain, all of which were among women aged 18 to 48. A special meeting of the CDC’s Advisory Committee on Immunization Practices will review the reports on 14 April, the FDA and CDC said in a joint statement. “Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” the statement said.

United-states , United-kingdom , Germany , Russia , Netherlands , Israel , Chile , Italy , Sweden , City-of-london , London , City-of

Covid-19 news: Cases in India hit record high as Kumbh Mela begins

REUTERS/Danish Siddiqui
Latest coronavirus news as of 5pm on 12 April
As millions gather to celebrate Kumbh Mela, India’s coronavirus cases surge, overtaking Brazil in total number of infections
India reported a record increase of 168,912 new coronavirus cases on 12 April, bringing the country’s total number of cases since the start of the pandemic to about 13.53 million. India’s tally is now the second-highest in the world, narrowly overtaking Brazil, but remaining below the 31.2 million cases reported so far in the US.
Advertisement
According to estimates from Johns Hopkins University, infections in India are on course to double in two months. Some officials have expressed concerns about crowding at religious festivals and political rallies. In the northern city of Haridwar almost a million people gathered by the Ganges river on 12 April to participate in the Hindu festival Kumbh Mela. “The police are continuously appealing to people to maintain social distancing,” Sanjay Gunjyal, a police official, told

United-kingdom , Spain , India , Brazil , Russia , Canada , Germany , Israel , Chile , City-of-london , London , City-of

Covid-19 news: EU drugs regulator reviewing Johnson & Johnson vaccine

Stephen Zenner/SOPA Images/Shutterstock
Latest coronavirus news as of 5pm on 9 April
The EU’s medicines regulator is reviewing a small number of reports of rare blood clots in people who received the Johnson & Johnson vaccine
The European Union’s medicines regulator is reviewing four reported cases of rare blood clots associated with low levels of platelets – small particles in the blood that normally help in clotting – including one case which was fatal, in people who received the Johnson & Johnson covid-19 vaccine. The European Medicines Agency (EMA) is also reviewing five reported cases of a bleeding condition, called capillary leak syndrome, in people who received the Oxford/AstraZeneca covid-19 vaccine. “At this stage, it is not yet clear whether there is a causal association” between the vaccines and the reported conditions, the EMA said. Both the Oxford/AstraZeneca and Johnson & Johnson vaccines are based on viral vector technologies, which use inactivated cold viruses to deliver genes encoding the coronavirus spike protein into the body to stimulate an immune response.

United-kingdom , India , Brazil , Israel , Poland , Russia , France , China , Germany , Sweden , Peru , Chile

Covid-19 news: Italy, Spain, Belgium limit use of AstraZeneca vaccine

Covid-19 news: Italy, Spain, Belgium limit use of AstraZeneca vaccine
newscientist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newscientist.com Daily Mail and Mail on Sunday newspapers.

United-kingdom , India , United-states , Australia , France , Poland , Russia , Spain , China , Germany , Sweden , Brazil

Covid-19 news: UK to offer under-30s alternative to AstraZeneca jab

Marco Cantile/LightRocket via Getty Images
Latest coronavirus news as of 5pm on 7 April
UK committee advises under-30s be offered alternative to AstraZeneca jab, while EU review finds no evidence age or gender are risk factors for side effects
The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that people under the age of 30 with no underlying health conditions should be offered an alternative covid-19 vaccine instead of the Oxford/AstraZeneca shot where possible, due to evidence linking the vaccine to rare blood clots. A review by the UK’s medicines regulator found that by the end of March, 79 people in the UK had experienced rare blood clots following vaccination with the Oxford/AstraZeneca vaccine – 19 of whom had died. The UK Medicines and Healthcare products Regulatory Agency (MHRA) said this was not definitive evidence that the vaccine caused the clots but said the link was becoming firmer. However, both the MHRA in the UK and the EU’s medicines regulator, which has also been reviewing reports of rare blood clots, emphasised that the benefits of the vaccine in preventing covid-19 continue to outweigh the risk of side effects. “The balance of benefits and risks is still very favourable for the majority of people,” said June Raine, chief executive of the MHRA, at a press conference on 7 April.

United-kingdom , United-states , Australia , France , Poland , Russia , Spain , Beijing , China , Germany , Sweden , Brazil

Covid-19 news: EMA says no verdict yet on AstraZeneca jab review

JOE KLAMAR/AFP via Getty Images
Latest coronavirus news as of 5pm on 6 April
The EU’s drugs regulator has been investigating reports of rare blood clots in a small number of people who received the vaccine
The European Union’s medicines regulator has denied that it has established an association between the Oxford/AstraZeneca covid-19 vaccine and rare blood clots, after an official from the agency claimed it had. Marco Cavaleri, chair of the vaccine evaluation team at the European Medicines Agency (EMA), told Italian newspaper
Il Messaggero that there is a “clear” link between the vaccine and an extremely rare blood clot in the brain, but did not provide any evidence to support his claim. In a statement on 6 April, the EMA said it had “not yet reached a conclusion and the review is currently ongoing”, adding that it expected to announce findings from the review on 7 or 8 April. It’s safety committee is investigating 44 reports of cerebral venous sinus thrombosis, an extremely rare blood clot in the brain, out of 9.2 million people in the European Economic Area who received the vaccine. Both the EMA and the World Health Organization have consistently emphasised that the benefits of the vaccine in preventing covid-19 outweigh its risks.

Uruguay , New-zealand , France , United-kingdom , Poland , Russia , White-house , District-of-columbia , United-states , Beijing , China , Germany